Carlisle Cos. (CSL) Tops Q2 EPS by 50c
Tweet
Share
E-mailGet Alerts CSL Hot Sheet
Price: $352.14 +2.06%
Revenue Growth %: +10.0%
Financial Fact:
Research and development expenses: 12.3M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +10.0%
Financial Fact:
Research and development expenses: 12.3M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Carlisle Cos. (NYSE: CSL) reported Q2 EPS of $5.18, $0.50 better than the analyst estimate of $4.68. Revenue for the quarter came in at $1.5 billion versus the consensus estimate of $1.59 billion.
For earnings history and earnings-related data on Carlisle Cos. (CSL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Bernstein SocGen Group Reiterates Outperform Rating on Zydus Lifesciences (ZYDUSLIF:IN)
- Lynx Equity sees Micron and SanDisk breakout as volatility normalizes
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
